Long-term efficacy of omalizumab in patients with conventional treatment-resistant vernal keratoconjunctivitis. Rev Alerg Mex [Internet]. 2018 Jul. 4 [cited 2026 Sep. 24];65(2):192-6. Available from: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/292